PANTHERx® Rare Partnering with Gilead Sciences, Inc. for the Distribution of LIVDELZI®
August 16, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United...
Read More
PANTHERx® Rare Partnering with ITF Therapeutics LLC for U.S. Distribution of DUVYZAT™
July 30, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United...
Read More
PANTHERx® Rare Appoints Bansi Nagji as CEO; Rob Snyder appointed Executive Chair
July 25, 2024 PITTSBURGH – PANTHERx® Rare, one of the nation’s largest and fastest growing rare disease specialty pharmacies,...
Read More
PANTHERx® Rare Pharmacy Wins Seventh Patient Choice Award
May 1, 2024 PITTSBURGH – For a seventh time, PANTHERx Rare has been recognized as the winner of the annual Independent Specialty...
Read More
PANTHERx® Rare Partnering with X4 Pharmaceuticals Inc. for the Distribution of XOLREMDI™ (mavorixafor), the First FDA-Approved Therapy Indicated for Use in Patients with WHIM Syndrome
April 29, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United...
Read More
KEEP & PANTHERx® Rare Forge Innovative Partnership to Advance the Specialty Therapy Experience in the Home
April 25, 2024 PITTSBURGH – An exciting advancement for the specialty pharmacy industry, KEEP announced a strategic partnership...
Read More